University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Cipaglucosidase alfa
Status: Red Cladribine injection

For hospital use only

Status: Amber Clobetasol propionate 0.05% cream

Very potent

Status: Amber Clobetasol propionate 0.05% ointment

Very potent

Status: Amber Clobetasol propionate 0.05% scalp application

Very potent

Status: Green Clobetasone butyrate 0.05% cream

Moderate potency

Status: Green Clobetasone butyrate 0.05% ointment

Moderate potency

Status: Green Clopidogrel 75mg tablets
Status: Amber Colistimethate sodium

Amber: Existing patients (initiated prior to April 2013)
Promixin® - Powder for nebuliser solution
Colomycin® Injection may be used for nebulisation; administer required dose in 2-4 mL of sodium chloride 0.9%, (or water for injections) or a 1:1 mixture of sodium chloride 0.9% and water for injection
Colobreathe® - Dry powder for inhalation, hard capsule (NICE TA276)

Status: Red Colistimethate sodium

NHS England commissioned for cystic fibrosis only. Red for new patients.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top